skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant (Code C2430)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant

Definition: A vaccine adjuvant consisting of a plasmid DNA encoding sargramostim (a granulocyte macrophage-colony stimulating factor). Upon administration, expressed sargramostim may stimulate a cytotoxic T cell response enhancing the host immune response to a concomitantly administered melanoma vaccine.

Label: Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant

NCI Thesaurus Code: C2430 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0393071  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
GM-CSF plasmid DNA melanoma vaccine
Sargramostim Plasmid DNA Melanoma Vaccine Adjuvant

External Source Codes: 
PDQ Closed Trial Search ID 42679
PDQ Open Trial Search ID 42679 (check for NCI PDQ open clinical trial info)
UMLS CUI C0393071

Other Properties:
     Name Value (qualifiers indented underneath)
code C2430
Legacy_Concept_Name Sargramostim_Plasmid_DNA_Melanoma_Vaccine
Semantic_Type Immunologic Factor
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom